The team of the Molecular and Therapeutic Pathology of Atherothrombotic and Ischemic Diseases “ICCC Cardiovascular Programme” research group, led by Dr. Lina Badimon, from the Sant Pau-IIB Sant Pau Research Institute, is participating in the COVIRNA project, which is coordinated by the Luxembourg Institute of Health (LIH). This is one of the 23 research projects that have been awarded within the framework of the Horizon 2020 call for Expression of Interest. The work aims to promote the development of a new diagnostic test to predict the results of Covid-19 for patients and to improve cooperation between European research institutions to strengthen the response to the pandemic.

més…

The Unit of Resistant Schizophrenia of the Sant Pau Psychiatric Service, led by Dr. Iluminada Corripio, the Research Group in Clinical Psychiatry of the Sant Pau Research Institute – IIB Sant Pau, led by Dr. Maria J. Portella, and the Research Group on Severe Mental Disorders of FIDMAG Hermanas Hospitalarias, led by Dr. Edith Pomarol-Clotet, all attached to the Center for Biomedical Research Network in Mental Health (CIBERSAM), have published the first trial in the world on the application of the surgical technique of deep brain stimulation (DBS) in patients with treatment resistant schizophrenia, which suggests that this procedure may be beneficial in some patients who do not respond adequately to any other treatment.

més…

Next Monday, November 23, at 6 pm, the conference will be held: “The long road to describe a new muscle disease” by Dr. Montse Olivé Plana. Dr. Olivé is a member of the Neuromuscular Diseases Research Group of the Sant Pau Research Institute – IIB Sant Pau and a specialist in the Neuromuscular Diseases Unit of the Sant Pau Hospital’s Neurology Service. This session is part of the Science Monday cycle and will be streamed.

More information

93% of patients with type 2 diabetes have a high or very high risk of fatal events such as heart attack or stroke within a decade. This is the conclusion of a study published in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC), in which researchers from the Sant Pau Research Institute- IIB Sant Pau have participated. In view of these data, the prevention of heart attacks and strokes in patients with type 2 diabetes treated in primary care should be an urgent priority.

més…

Fighting the bad guys involved in abdominal aortic aneurysm is the challenge that the super-scientists explain in their one-minute video, which received the highest score from the CIBER jury in the #QueSigaLaCiencia call for entries. Lídia Puertas, from the Research Group Regulatory Mechanisms of Cardiovascular Remodeling at the Sant Pau-IIB Sant Pau Research Institute, and Saray Varona, researcher at the CIBER of Cardiovascular Diseases (CIBERCV) at the Spanish National Research Council (CSIC), thus become superheroines fighting this cardiovascular disease.Lídia Puertas y Saray Varona, premiadas en la primera convocatoria de vídeos #QueSigaLaCiencia del CIBER.

més…

Saúl Martínez-Horta, neuropsychologist of the Movement Disorders Unit of the Sant Pau Neurology Service, and of the Parkinson’s Disease and other Movement Disorders Research Group of the Sant Pau Research Institute -IIB Sant Pau, has been awarded the best oral communication presented at the LXXII Annual Meeting of the Spanish Society of Neurology (SEN), in the category of Movement Disorders.

més…

On November 18, at 6.30 pm, Dr. Amalia Sillero, surgical nurse at the Hospital de Sant Pau and researcher of the Nursing Care Research Group of the Sant Pau Research Institute – IIB Sant Pau, will give a lecture on “The application of the values of magnetism in the surgical area of a high-tech hospital”, the subject of her doctoral thesis. The session will be done in streaming.

More information

The Memory Unit of the Sant Pau Neurology Service and the Neurobiology of Dementia Research Group of the Sant Pau Research Institute, led by Dr. Alberto Lleó, have participated in a study on the impact of Covid-19 on individuals with Down syndrome. This work has been developed and carried out by the T21RS Covid-19 working group. The report contains information on symptoms, risk factors and outcomes after a diagnosis of Covid-19 in people with Down syndrome.

més…

On 10 and 11 November the “I VATS Course in Animal Model” will be held in Sant Pau. This course is aimed at surgeons who are particularly interested in thoracoscopic surgery and combines the technique in the animal model with the broadcast of a live surgery. The lecturers are Dr. Belda, Dr. Cladellas, Dr. Martínez and Dr. Trujillo-Reyes, all from the Sant Pau Thoracic Surgery Service. Attached you will find the course programme.

2020-11 ProgramaVATSmodeloAnimal

On 16 November at 6 pm, Dr. José Manuel Soria, head of the Genomics of Complex Diseases Research Group at the Sant Pau Research Institute – IIB Sant Pau and scientific director of Exheus, will give the conference “Risk of thrombosis associated with Covid-19”. For more information, see the programme with the next conferences in the cycle.

més…

Dr. Pere Domingo, coordinator of the HIV and AIDS Research Group of the Sant Pau Research Institute -IIB Sant Pau, will give the webinar “Covid-19 pharmacological interventions” today, 4 November. This seminar forms part of the joint scientific dissemination action of the Alliance of Health Research and Innovation Institutes of Catalonia (IRISCAT), which has organised a series of webinars that will deal with different topics related to biomedical research and Covid-19. The appointment is at 4 pm and registration is free.

més…

The CARDIOPATCH project, a territorial cooperation project (Interreg Sudoe Programme) financed through European FEDER funds, will involve the Sant Pau. Dr. Lina Badimon and Dr. Gemma Vilahur, from the ICCC Program of the Research Institute of the Hospital de Sant Pau – IIB Sant Pau, will contribute to the development of functionalized patches with therapeutic proteins and enriched with improved stem cells that aim to promote the regeneration of infarcted tissue.

The 2019 Scientific Report of the Sant Pau Biomedical Research Institute (IIB Sant Pau) is now available. You can consult it on its website.

Dr. Kulisevsky, director of the Movement Disorders Unit of the Sant Pau Hospital Neurology Service and head of the Parkinson’s Disease and Movement Disorders Research Group at the Sant Pau Research Institute, is the principal investigator and international coordinator of a controlled phase 2 drug study that, for the first time in 20 years, is achieving positive results for cognitive complications in Parkinson’s disease. Sant Pau Hospital has also participated as a patient recruitment centre for the study.

Annex

Luciana Martel, PhD student and member of the Pituitary Diseases Research Group at the Sant Pau Research Institute -IIB Sant Pau, led by Susan Webb, has received the award for best paper from the Neuroendocrinology Area for her work “Gender Dimorphism in Skeletal Muscle Fat Infiltration and Associated Muscle Dysfunction in Patients with Controlled Acromegaly” at the congress of the Spanish Society of Endocrinology and Nutrition (SEEN), which was recently held in virtual format.

On 28 October, the “Orphan Drug Designation, Development and Access” conference will take place online for the first time. Among other speakers, Dr. Jordi Minguillón, a researcher with the Sant Pau Research Institute’s Genomic Instability Syndromes and DNA Repair research group, and Dr. Josep Torrent-Farnell, pharmacologist and coordinator of rare diseases and orphan drugs at the Sant Pau Hospital’s Clinical Pharmacology Service, will participate in the conference. Attached you will find the programme and the registration forms.

Journey Programme Online MMHH 2020

Today, 19 October, World Breast Cancer Day, the Hospital de Sant Pau also commemorates the fact that the female team formed by Dr. M. Carmen Alonso and Dr. Montserrat Baiget, both from the Hospital de Sant Pau, were pioneers in the study of hereditary breast and ovarian cancer by searching for the mutations in the BRCA 1 and 2 genes that predispose to these two types of disease. The Hospital de Sant Pau currently has one of the largest genetic databases in the world with over 2,000 samples.

més…

On the occasion of World Thrombosis Day, the Sant Pau Modernist Site is hosting a commemorative event on Friday 20 November from 5 p.m. to present the ACTIVA’TT Association and its activities in the field of research and prevention. The Mobile Centre for the Evaluation of Vascular Diseases, the Association’s main tool for raising funds to finance research projects at the Sant Pau Research Institute, will also be presented.

més…

The Cerebral Vascular Disease research group, led by Dr. Joan Martí Fàbregas, inaugurates the Sessions of experts in #patologiavascularcerebral of the @scatalananeuro (Catalan Neurology Society) at the IIB Sant Pau in online format. If you want to connect, the appointment is tomorrow Friday, 10/09 at 8:30 am through the following link: https://lnkd.in/ekATWex

An investigation by the Research Groups of the Neuromuscular Diseases Unit (Alonso-Pérez and Díaz-Manera) and of Genetic Diseases (Gallano and González-Quereda), of the Sant Pau Research Institute- IIB Sant Pau, has recently been published in the Brain journal. The results of the study, in which 33 hospitals from 13 European countries participated and which collected clinical and genetic data from 439 muscular dystrophy patients, will help to design new clinical trials in a more rational way, while indicating that those therapies that induce protein expression above 30% can produce a significant change in the natural history of the disease.

més…